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The role of gut bacteria in modulating gastrointestinal physiology is increasingly being appreciated. In a
recent issue ofCell, Dey et al. (2015) report how a single dietary ingredient—turmeric—interacts with gut bac-
teria to alter gastrointestinal motility.Gastrointestinal (GI) motility enables mix-
ing, storage, anterograde propulsion and
absorption of nutrients, and represents
one of the most important functions of
the GI tract. GI transit time, the time for a
food bolus to pass through the GI tract,
is often used as a surrogate for GI motility.
This seemingly simple process requires
coordination among several key cell types
in the enteric neuromuscular apparatus,
including the enteric neurons and glia,
interstitial cells of Cajal (ICC), smooth
muscle, and immune cells. Until recently,
the majority of the work on GI motility dis-
orders has focused on the interplay
among different host cell types, even
though it is established that gut bacteria
and luminal compounds have a significant
impact on GI motility. However, recent
studies have started to uncover this addi-
tional layer of complexity, exploring how
gut microbiota and their products influ-
ence host GI physiology.
Studies of gut microbiota and neuro-
muscular apparatus, including neuro-
transmitters in the context of GI motility,
have shown that gut microbiota and their
products have effects on the enteric neu-
rons, enteric muscularis macrophages,
and enteric glia. Gut microbiota-derivedlipopolysaccharide (LPS) improves en-
teric neuronal survival and influences GI
motility (Figure 1), acting via the TLR4
and NF-kB pathway (Anitha et al., 2012).
Gut microbiota products also influence
the crosstalk between enteric neurons
and muscularis macrophages (Figure 1),
which plays an important role in maintain-
ing normal GI motility (Muller et al., 2014).
Serotonin, an important neurotransmitter
in the gut that plays a role in modulating
GI motility, can be modulated by gut mi-
crobes (Reigstad et al., 2015). Metabo-
lites resulting from primary and secondary
fermentation of dietary nutrients by gut
microbes, such as short-chain fatty acids
and bile acids (Figure 1), can increase se-
rotonin biosynthesis and release in the
gut, thereby altering GI motility in a diet-
dependent manner (Kashyap et al., 2013).
The new study by Dey et al. (2015) pro-
vides an in-depth investigation of the
interaction between diet and gut micro-
biota to elucidate the mechanisms by
which these interactions influence GI
motility. Travelers’ diarrhea is common
during travel to the developing world and
is often attributed to acquisition of patho-
genic bacteria or viruses. However, an
additional aspect of travel is short-termexposure to new diets. Diet is a dominant
factor in shaping gut microbial commu-
nities (Wu et al., 2011) and has been
shown to influenceGImotility in both ami-
crobiota-dependent and independent
manner (Kashyap et al., 2013). In a series
of elegant experiments, the authors
subject gnotobiotic mice, colonized with
microbiota from healthy human donors
(humanized) from across the world, to
multiple cycles of short-term dietary inter-
ventions, representing native and non-
native diets. The authors were able to
identify several bacterial taxa present in
different groups of humanized mice that
have diet-dependent effects on GI transit.
Some of these taxa (e.g., E. desmolans)
had opposite correlations with transit
time depending on supplementation with
native or non-native diet. As expected,
diet also showed effects on gut micro-
biota that did not correlate with GI transit
time.
In order to investigate bacterial media-
tors of the dietary effects on GI transit,
Dey et al. (2015) quantified bile acid me-
tabolites in the stool. They found that
faster transit time was associated with
an increase in unconjugated bile acids, re-
sulting from the activity of bacterial bile, October 14, 2015 ª2015 Elsevier Inc. 385
Figure 1. Microbiota-Mediated Pathways that Affect GI Transit
Diet-gut microbiota interaction results in a large array of metabolites. In the presence of dietary turmeric,
gut microbial communities with high bile-salt hydrolase activity make higher amounts of unconjugated bile
acids, which influence enteric nervous system signaling and lead to faster GI transit. Dietary fermentation
by gut microbiota results in formation of short chain fatty acids which affect GI motility by effects on gut
neuromuscular apparatus and the host serotonergic pathway. LPS and other bacterial products are
implicated in improving neuronal survival as well as affecting enteric neuron-muscularis macrophage
crosstalk. Gut microbiota are required for the postnatal development and generation of new enteric glia.
LPS, lipopolysaccharide; GDNF, glia-derived neurotrophic factor; TLR-4, Toll-like receptor 4; 5HTR, 4
5-hydroxytryptamine receptor-4; ICC, interstitial cells of Cajal.
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Previewssalt hydrolases. In order to determine how
a single dietary ingredient can interact
with gut microbiota and change bile acid
composition in the gut, the authors used
turmeric, a commonly used spice in south
Asia. While turmeric contains the natural
anti-inflammatory phytochemical curcu-
min, it is also known for its cholekinetic ef-
fect, or the ability to stimulate bile acid
secretion into the gut lumen. Gnotobiotic
mice, colonized with a clonally arrayed
bacterial culture collection from a child386 Cell Host & Microbe 18, October 14, 201from Bangladesh, were found to have
significantly higher conjugated bile acids
(taurohyodeoxycholic acid and tauromur-
icholic acid sulfate) and longer GI transit
time in the presence of turmeric com-
pared to unsupplemented animals, high-
lighting the effect of a single dietary ingre-
dient on gut microbial products and GI
transit (Figure 1). The authors screened
members of this clonally arrayed bacterial
culture collection for their bile salt hydro-
lase activity and assembled two bacterial5 ª2015 Elsevier Inc.consortia, one with low bile salt hydrolase
activity (Enterococcus, Eggerthella, and a
member of Enterobacteriaceae) and the
other with high bile salt hydrolase activity
(Enterococcus and three members of
Bifidobacterium) to examine the effect of
turmeric on microbial communities with
differing capacities to deconjugate bile
acids and on GI transit time. Interestingly,
in the presence of turmeric, gnotobiotic
mice colonized with a cultured microbial
community with low bile salt hydrolase
had significantly longer GI transit time,
lower bile salt hydrolase expression, and
lower levels of unconjugated bile acids
as compared to gnotobiotic mice colo-
nized with a microbial community with
high bile salt hydrolase activity.
The role of bile acids in GI physiology
has been well studied. Bile acids can
stimulate intestinal secretion of fluid and
electrolytes, increase mucosal perme-
ability by acting as emulsifying agents,
and induce high-amplitude propagated
contractions, therebyaccelerating colonic
transit (Camilleri, 2014). The recently
described membrane-bound bile acid
receptor TGR5, which is expressed in
enteric neurons and colonic epithelial
cells, can regulate smooth muscle con-
traction and intestinal secretion. Bile acid
malabsorption is associated with diar-
rhea, and can be seen in ileal Crohn’s dis-
ease, postcholecystectomy, small intesti-
nal bacterial overgrowth, irritable bowel
syndrome (IBS), and other similar disor-
ders. Interestingly, while gut microbiota
play a key role in deconjugating bile acids
and are important regulators of the total
bile acid pool as well as their composition,
only recently has the role of gutmicrobiota
in bile acid metabolism been described in
GI diseases. In fact, disturbances in bile
acid metabolism with an increase in pri-
mary bile acids, in association with alter-
ation in gut microbial communities (e.g.,
increase in E.coli and decrease in Leptum
and Bifidobacterium in patients with diar-
rhea-predominant IBS), was recently re-
ported in IBD and IBS (Duboc et al.,
2012, 2013).
The enteric nervous system plays an
important role in maintaining normal GI
motility, and hence the authors next went
on to test if the diet-microbiota interaction
affects GI transit by modulating enteric
nervous system signaling (Figure 1). Inter-
estingly, they found the difference in GI
transit between the high and low bile salt
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plemented with turmeric, was lost when
these communities were introduced into
germ-free RET+/ mice, but was retained
in wild-type animals. RET encodes a
transmembrane protein that forms part of
the receptor for glia-derived neurotrophic
factor (GDNF) family signaling peptides.
Loss-of-function mutations in RET ac-
count for the largest proportion of cases
of Hirschsprung’s disease, a hereditary
developmental disorder where peristalsis
is absent in the colon due to lack of
neuronal development. Interestingly, a
recent paper investigating the effect of
gut microbiota on enteric glia (Figure 1)
found that the gut microbiota plays an
important role both in postnatal develop-
ment as well as sustaining generation of
newmucosal enteric glial cells (Kabouridis
et al., 2015). Given that theGDNF family of
peptides from enteric glia are ligands for
RET on enteric neurons, one may specu-
late that the effect of gut microbiota prod-
ucts on RET proposed in the current study
is potentially downstreamof their effect on
enteric glia. These findings, which impli-
cate the gut microbiota in potential inter-
actions between key cell types affecting
GI motility, open several new avenues to
be explored in future studies.
In summary, the study by Dey et al.
(2015) provides novel insights into the
mechanisms by which interaction of die-
tary ingredients and gut microbiota influ-
ence the enteric nervous system to alter
GI transit time. This finding has importantimplications, not only for variations in
transit time seen with travel and rapid
dietary cycling, but also for developing
microbiota-targeted therapies in chronic
GI disorders associated with microbial
dysbioses, including IBS and IBD,
wherein some symptoms are commonly
attributed to dietary intolerance. This
and the other recent studies highlight
the layers of complexity with crossking-
dom signaling in the regulation of GI
motility as we start to investigate the
role of gut microbiota in this important
process. As the field advances, we
hope to have a better understanding of
the effects of bacteria and their products
on the key cell types in the enteric neuro-
muscular apparatus and the interactions
among them. The findings of Dey et al.
(2015) raise several additional questions
which will need to be addressed in future
studies, including the mechanisms by
which bacteria-mediated processes in-
fluence (1) RET gene function and down-
stream signaling pathways; (2) other key
cells types involved in GI motility; and
(3) and development and interaction
among different cell types in the gut
such as enteric glia, enteric neurons,
ICC, and macrophages.
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